New endoscope to target colon tumours

May 10, 2017

European scientists are working on the development of an innovative, compact and easy-to-use endoscopic device for identifying and diagnosing preprecancerous polyps and early colon cancers. Worldwide, colon cancer remains the third most common cancer in men, behind lung and prostate cancer, and second in women, behind breast cancer.

Colorectal ranks as one of the world's most predominant cancers, affecting approximately one in ten people during their life and causing almost 700,000 annual deaths globally. Almost 95 percent of these cases are adenocarcinomas, which typically start as a growth of tissue called a polyp.

Today, the main method to achieve early detection of the disease is colonoscopy. While up to 40 percent of the patients under routine analysis colonoscopy present one or more , almost 30 percent of these polyps are not detected, especially in the case of flat polyps. Of those detected, 29 to 42 percent are generally hyperplastic, and will not develop into cancer. The remainder are neoplastic polyps, which are of primary importance because they harbor malignant potential and represent a stage in the development of . For this reason, it is essential to identify these polyps at an early stage.

Speaking about the PICCOLO Project Dr. Artzai Picon (Tecnalia) said "We hope that PICCOLO will provide major benefits over traditional colonoscopy. Firstly, by developing an advanced endoscope, using both (OCT) and multi-photon tomography (MPT), we will provide high-resolution structural and functional imaging, giving details of the changes occurring at the cellular level comparable to those obtained using traditional histological techniques. Furthermore, when multiple polyps are detected in a patient, the current gold standard procedure is to remove all of them, followed by microscopic tissue analysis. Removal of hyperplastic polyps, which carry no malignant potential, and the subsequent costly histopathological analysis, might be avoided through the use of the PICCOLO endoscope probe, which could allow image-based diagnosis without the need for tissue biopsies."

The long-term potential for this project is exciting. Not only will it provide a new approach in colon cancer detection, but the new image-based diagnosis methods could be applied to diseases in other organs of the body. The PICCOLO team hope to refine their first prototype by the end of 2018 and begin clinical trials around 2020.

Explore further: Technology advances help to prevent, lessen impact of colon cancer

Related Stories

Technology advances help to prevent, lessen impact of colon cancer

March 14, 2017
Approximately 140,000 people are diagnosed with colorectal cancer in the U.S. each year. March is Colorectal Cancer Awareness Month.

Review: Colon capsule endoscopy accurate in polyp detection

November 1, 2016
(HealthDay)—Colon capsule endoscopy (CCE), especially second-generation CCE (CCE-2), has high sensitivity and specificity for detecting colorectal polyps, according to a review published in the November issue of Clinical ...

Certain types of polyps may warrant keeping closer tabs on the colon

April 13, 2016
Being on the lookout for certain features of polyps may help physicians keep a closer eye on patients at risk for colorectal cancer.

Post-polyp detection, CRC risk ID'd by colonoscopy factors

August 21, 2012
(HealthDay) -- In the community setting, after colonoscopic polyp detection, colonoscopy-related factors such as incomplete polyp removal and lack of surveillance colonoscopies are more important than polyp characteristics ...

Estimating the risk of bowel cancer

August 19, 2013
Polyps in the mucosa of the colon are a common finding during screening colonoscopies. Some sub-groups of polyps are classed as precursors of bowel cancer. Until now, it has not been possible to precisely estimate the risk ...

Recommended for you

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.